Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life.

Source:http://linkedlifedata.com/resource/pubmed/id/19439100

Download in:

View as

General Info

PMID
19439100